Sanofi Plans to Cut the Price of Insulin
Facing pressure to follow a wave of industry price cuts, the drug maker Sanofi said on Thursday that it would reduce the sticker price of its most commonly used insulin by 78 percent. The company said it would also cap, at $35 per month, that product’s out-of-pocket costs for diabetes patients with private health plans.…
Details